Inflammatory joint processes
I-ONE® therapy favours the functional recovery time and reduces the NSAIDs consumption.
Treatment protocol: 4 hours per day for 30-60 days.
Bone marrow edema
I-ONE® therapy significantly enhances the process of bone edema resorption.
I-ONE® therapy can be successfully used to treat patients with symptomatic bone marrow edema of the knee or to treat symptomatic cartilage lesions.
Treatment protocol: 4 hours per day for 30-60 days.
Early stages of osteoarthritis
I-ONE® therapy leads to significant improvement in symptoms, pain, knee function and activity level. Annual repetition of the treatment may result in sustained symptomatic improvement for the patient.
Treatment protocol: 4 hours per day for 30-60 days.
Complex Regional Pain Syndrome (CRPS)
I-ONE® therapy significantly reduces swelling and articular pain improving joint mobilization during physiotherapy sessions.
In this patient I-ONE® therapy successfully controlled the pain and swelling allowing for a complete functional recovery of the wrist and finger.
Treatment protocol: 4 hours per day for 30-60 days.
Spontaneous OsteoNecrosis of the Knee (SONK)
I-ONE® therapy is beneficial for bone healing and for the resolution of bone marrow edema (85% of cases), thus reducing the symptoms and contributing to the good/excellent result in 75% of patients.
This treatment increases knee function and preserves 76% of knees from prostheses surgery (at 2 years follow-up). The benefit produced by I-ONE® therapy is maintained for up to two years after treatment.
Treatment protocol: 4 hours per day for 30-60 days.
Patellofemoral Pain Syndrome
Pain reduction obtained with I-ONE® therapy enhances the practicing of therapeutic exercises leading to a better recovery process; this is extremely important in addressing the expectations of young patients, who wish to return to sporting activities.
Treatment protocol: 4 hours per day for 30-60 days.
